Livzon Pharmaceutical Group Inc. provided earnings guidance for the period from 1 January 2017 to 31 December 2017. For the year, the company expects Net profit attributable to the shareholders of the company to be increased by approximately 451.04% - 470.56% as compared to the corresponding period last year, profit of approximately RMB 4,322.0717 million to RMB 4,475.1744 million. Basic earnings per share to be approximately RMB 7.90 to RMB 8.18 per share.